Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone in Recurrent Prostate Cancer
NCT00182052Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2000
- Primary completion
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rosiglitazone in prostate cancer (PCa), sponsored by Massachusetts General Hospital. Started Sep 2000; status: completed.
02
Drugs
rosiglitazone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00182052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182052.